- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Atherton Today
By the People, for the People
Amaros Launches Interventional Glaucoma Network
New initiative aims to advance evidence-based treatments for glaucoma patients.
Mar. 31, 2026 at 1:24pm
Got story updates? Submit your updates here. ›
The Interventional Glaucoma Network aims to advance minimally invasive treatments that could preserve vision for millions of patients living with this chronic eye condition.Atherton TodayAmaros, a leading medical technology company, has announced the launch of the Interventional Glaucoma Network, a collaborative effort to advance the field of interventional glaucoma and improve outcomes for patients living with the chronic eye condition.
Why it matters
Glaucoma is a leading cause of irreversible blindness worldwide, and interventional treatments offer promising alternatives to traditional glaucoma management. The Interventional Glaucoma Network will bring together experts to drive research, share best practices, and advocate for increased access to these innovative therapies.
The details
The Interventional Glaucoma Network will facilitate collaboration among ophthalmologists, researchers, and industry partners to accelerate the development and adoption of minimally invasive glaucoma surgeries (MIGS) and other interventional approaches. The network will focus on generating real-world evidence, conducting clinical trials, and educating healthcare providers and patients about the benefits of these treatments.
- Amaros announced the launch of the Interventional Glaucoma Network on March 31, 2026.
The players
Amaros
A leading medical technology company that develops innovative solutions for the treatment of glaucoma and other eye conditions.
What they’re saying
“We are excited to launch the Interventional Glaucoma Network and bring together the brightest minds in ophthalmology to drive progress in this critical area of patient care.”
— Dr. Emily Chen, Chief Medical Officer, Amaros
What’s next
The Interventional Glaucoma Network plans to host its first annual conference in June 2026, where members will share research findings, discuss best practices, and explore new avenues for collaboration.
The takeaway
The launch of the Interventional Glaucoma Network represents a significant step forward in the quest to improve treatment options and outcomes for the millions of people living with glaucoma worldwide. By fostering cross-disciplinary collaboration and evidence-based innovation, this initiative has the potential to transform the way this debilitating condition is managed.
